SALMONELLA-HIV CHIMERA AS VACCINE

沙门氏菌-HIV 嵌合体作为疫苗

基本信息

  • 批准号:
    2064048
  • 负责人:
  • 金额:
    $ 27.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-12-01 至 1994-11-30
  • 项目状态:
    已结题

项目摘要

The long-term objective is to construct Salmonella-based anti-HIV vaccine strains for trial in volunteers, consisting of an aromatic-dependent strain of S. typhi (needing p-aminobenzoate, not available in host tissues, therefore non-pathogenic) carrying genetic information such that its administration will cause humoral and cellular immune responses to both the bacterial carrier and to the HIV epitope encoded by the passenger DNA. The foreign DNA will be a short synthetic oligonucleotide specifying an amino acid sequence identified as an epitope of an HIV protein antigen able to cause production of virus-neutralizing antibody or other protective response. The oligo will be inserted in a cloned flagellin gene at a point such that the amino acid sequence it specifies is exposed at the flagellar surface, accessible to antibody and expected to be highly immunogenic. Another form of the vaccine will consist of flagella broken off from the live-vaccine bacteria, concentrated and purified for use as a product vaccine, to be given by injection. Specific Aim 1 is to test immune responses of mice and guinea pigs to parenteral or oral administration of a Salmonella live vaccine with flagella made of flagellin specified by a cloned gene with oligos determining short amino acid sequences from gp160 of HIV inserted at the EcoRV site, by use of already constructed or to be made derivatives of plasmid pLS408 placed in a flagellin-negative aroA live-vaccine strain of S. dublin. Aim 2 is development of a method for quantitation of flagellin and the investigation of what features of an amino acid insert determine continued production of flagella or the accumulation or secretion of flagellin without production of flagella; and of genetic methods of increasing amount of flagellin produced by a strain and the effect on immunogenicity, etc, of having two or more inserts, specifying the same or different epitopes, in tandem in a single flagellin molecule. Aim 3 is the construction of a replacement for a live-vaccine strain of S. typhi already tested in volunteers by one attenuated by two deletions in the aro (aromatic biosynthesis) pathway, instead of by an aroA deletion and a purA deletion, and investigation of effect of variation of parameters of dosage, presentation, etc, on efficacy of orally administered live vaccine.
长期目标是构建基于沙门氏菌的抗hiv疫苗

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aromatic-dependent Salmonella as live vaccine presenters of foreign epitopes as inserts in flagellin.
芳香族依赖性沙门氏菌作为活疫苗呈递器,将外来表位插入鞭毛蛋白中。
  • DOI:
    10.1016/0923-2508(90)90112-4
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Stocker,BA
  • 通讯作者:
    Stocker,BA
Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin.
插入沙门氏菌鞭毛中的链球菌 M 蛋白表位的表达和免疫原性。
  • DOI:
    10.1128/iai.59.6.2158-2165.1991
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Newton,SM;Kotb,M;Poirier,TP;Stocker,BA;Beachey,EH
  • 通讯作者:
    Beachey,EH
Immunogenicity of Nef protein of SIVSMM-PBj14 expressed in a live vaccine strain of Salmonella species.
在沙门氏菌活疫苗株中表达的 SIVSMM-PBj14 的 Nef 蛋白的免疫原性。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRUCE A STOCKER其他文献

BRUCE A STOCKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRUCE A STOCKER', 18)}}的其他基金

ENHANCING IMMUNOGENICITY OF EPITOPE INSERTS IN FLAGELLIN
增强鞭毛蛋白表位插入的免疫原性
  • 批准号:
    3148642
  • 财政年份:
    1992
  • 资助金额:
    $ 27.79万
  • 项目类别:
ENHANCING IMMUNOGENICITY OF EPITOPE INSERTS IN FLAGELLIN
增强鞭毛蛋白表位插入的免疫原性
  • 批准号:
    2068620
  • 财政年份:
    1992
  • 资助金额:
    $ 27.79万
  • 项目类别:
ENHANCING IMMUNOGENICITY OF EPITOPE INSERTS IN FLAGELLIN
增强鞭毛蛋白表位插入的免疫原性
  • 批准号:
    3148643
  • 财政年份:
    1992
  • 资助金额:
    $ 27.79万
  • 项目类别:
SALMONELLA-HIV CHIMERA AS VACCINE
沙门氏菌-HIV 嵌合体作为疫苗
  • 批准号:
    3141946
  • 财政年份:
    1988
  • 资助金额:
    $ 27.79万
  • 项目类别:
SALMONELLA-HIV CHIMERA AS VACCINE
沙门氏菌-HIV 嵌合体作为疫苗
  • 批准号:
    3141948
  • 财政年份:
    1988
  • 资助金额:
    $ 27.79万
  • 项目类别:
SALMONELLA-HIV CHIMERA AS VACCINE
沙门氏菌-HIV 嵌合体作为疫苗
  • 批准号:
    3141945
  • 财政年份:
    1988
  • 资助金额:
    $ 27.79万
  • 项目类别:
SALMONELLA-HIV CHIMERA AS VACCINE
沙门氏菌-HIV 嵌合体作为疫苗
  • 批准号:
    3141947
  • 财政年份:
    1988
  • 资助金额:
    $ 27.79万
  • 项目类别:
AUXOTROPHY AND VIRULENCE
营养缺陷型和毒力
  • 批准号:
    3128257
  • 财政年份:
    1984
  • 资助金额:
    $ 27.79万
  • 项目类别:
AUXOTROPHY AND VIRULENCE
营养缺陷型和毒力
  • 批准号:
    3128258
  • 财政年份:
    1984
  • 资助金额:
    $ 27.79万
  • 项目类别:

相似海外基金

Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
  • 批准号:
    10432065
  • 财政年份:
    2019
  • 资助金额:
    $ 27.79万
  • 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
  • 批准号:
    9978709
  • 财政年份:
    2019
  • 资助金额:
    $ 27.79万
  • 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
  • 批准号:
    10201474
  • 财政年份:
    2019
  • 资助金额:
    $ 27.79万
  • 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
  • 批准号:
    10653943
  • 财政年份:
    2019
  • 资助金额:
    $ 27.79万
  • 项目类别:
Virus like particles as carriers for carbohydrate based anti-Salmonella vaccines
病毒样颗粒作为碳水化合物抗沙门氏菌疫苗的载体
  • 批准号:
    9118056
  • 财政年份:
    2015
  • 资助金额:
    $ 27.79万
  • 项目类别:
Virus like particles as carriers for carbohydrate based anti-Salmonella vaccines
病毒样颗粒作为碳水化合物抗沙门氏菌疫苗的载体
  • 批准号:
    8823965
  • 财政年份:
    2015
  • 资助金额:
    $ 27.79万
  • 项目类别:
Rabbit model to assess reactogenicity and immunogenicity of Salmonella vaccines
用于评估沙门氏菌疫苗反应原性和免疫原性的兔模型
  • 批准号:
    8607893
  • 财政年份:
    2013
  • 资助金额:
    $ 27.79万
  • 项目类别:
Rabbit model to assess reactogenicity and immunogenicity of Salmonella vaccines
用于评估沙门氏菌疫苗反应原性和免疫原性的兔模型
  • 批准号:
    8490135
  • 财政年份:
    2013
  • 资助金额:
    $ 27.79万
  • 项目类别:
Evaluation of Protein Channel-Attenuated Salmonella Vaccines
蛋白质通道减毒沙门氏菌疫苗的评价
  • 批准号:
    7849975
  • 财政年份:
    2009
  • 资助金额:
    $ 27.79万
  • 项目类别:
Evaluation of Protein Channel-Attenuated Salmonella Vaccines
蛋白质通道减毒沙门氏菌疫苗的评价
  • 批准号:
    7661304
  • 财政年份:
    2009
  • 资助金额:
    $ 27.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了